Phase 1 study

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor Shanghai Argo Biopharmaceutical Co., Ltd.
Registry number NCT07584876
Started 29 May 2026 Today 16 October 2026 Estimated completion 30 October 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Argo Investigative Site Perth WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 65 Years
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 40

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Must have given written informed consent and be able to comply with all study requirements

* Males or females aged 18 to 65 years old, inclusive, at the time of informed consent

* Body mass index (BMI) ≥18.0 and ≤32.0 kg/m2 and body weight ≥50.0 kg.

* APTT, PT, INR, and FXI activity within the normal range at screening

* Agree to avoid activities that can increase the risk of severe bleeding

* Female participants must be non-pregnant

* Male participants with female partners of child-bearing potential must agree to use acceptable methods of contraception from screening until 360 days following administration of the study drug

Exclusion Criteria:

* Any clinically significant chronic medical condition or clinically significant abnormality in laboratory parameters

* Any skin condition and/or tattoo

* Hospitalization for any reason within 60 days prior to screening

* History or presence of cancer

* Any clinically significant acute condition

* Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg after at least 5 minutes resting

* Clinical laboratory findings outside of range

* Any liver function panel analyte value \> 1.2 × upper limits of normal (ULN)

* Positive for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) antibody

* Single 12-lead ECG with clinically significant abnormalities at screening or Day -1

* Use of an investigational agent

* .Used of prescription drugs

* History or clinical evidence of alcohol substance abuse

* History or clinical evidence of drug abuse

* Positive test for alcohol or drugs of abuse at screening or Day -1

* Donated or lost \>200 mL of blood

* .Any conditions which, in the opinion of the Investigator

Dates on the record

Started 29 May 2026
Estimated completion 30 October 2027
Registry last updated 9 July 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 9 July 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.